1. Home
  2. FTW.WS vs RNAZ Comparison

FTW.WS vs RNAZ Comparison

Compare FTW.WS & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTW.WS

Presidio Production Company Warrants each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share

N/A

Current Price

$1.01

Market Cap

29.6M

Sector

Energy

ML Signal

N/A

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

SELL

Current Price

$1.33

Market Cap

27.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FTW.WS
RNAZ
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
27.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FTW.WS
RNAZ
Price
$1.01
$1.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
★ 17.7K
Earning Date
N/A
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.30
52 Week High
N/A
$12.60

Technical Indicators

Market Signals
Indicator
FTW.WS
RNAZ
Relative Strength Index (RSI) N/A 31.66
Support Level N/A N/A
Resistance Level N/A $1.93
Average True Range (ATR) 0.00 0.15
MACD 0.00 -0.02
Stochastic Oscillator 0.00 4.03

Price Performance

Historical Comparison
FTW.WS
RNAZ

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: